| Name | Title | Contact Details |
|---|
CoolSystems, Inc. is a Alameda, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Siemens Nixdorf is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.
MedicSight is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
In 1989, Travis Medical was created and incorporated by the Yule family. At that time, it was started with the simple goal to function as a profitable entity while serving the disabled community with dignity and respect. With humble beginnings Travis Medical spent the early portion of the 1990`s operating out of a single suite at their original 34th St. location in the medical district of Austin, TX. With few employees and a single goal, the Yule`s embraced the laid-back culture of Austin and offered an invitation to customers and employees alike to become a member of the extended family. This approach resonated with the medical community in Austin and, with time, Travis Medical began to experience growth.
Founded in 2011, Sight Sciences develops and commercializes intelligently designed and engineered products that target the underlying causes of the world`s most prevalent eye diseases. The company`s surgical glaucoma product portfolio features the OMNI Surgical System, a dually indicated MIGS device that facilitates the performance of both ab interno trabeculotomy and transluminal viscoelastic delivery. Using proprietary multi-modal functionality, OMNI allows surgeons to target all three sources of resistance in the conventional outflow pathway (trabecular meshwork, Schlemm`s canal and collector channels) with a single device and single corneal incision. The company`s non-surgical dry eye product portfolio consists of the TearCare for ophthalmologists and optometrists. TearCare is a software-controlled, wearable, therapeutic eyelid technology designed to melt and clear obstructions of the meibomian glands within the eyelids. Leveraging the full functionality of the blinking eye, proprietary SmartLid™ technology is designed to conform to all eyelid anatomies and achieve therapeutic meibum melting temperatures at the tarsal conjunctiva thereby clearing meibomian gland obstructions while sparing the cornea. Improved meibum production results in a higher quality lipid layer and higher quality tears.